Hyperfine (HYPR) Return on Capital Employed (2021 - 2026)
Hyperfine's (HYPR) quarterly Return on Capital Employed came in at 72.91% in Q1 2026, up 1736.0% YoY from 3.97% in Q1 2025, and up 27.93% on a QoQ basis from 101.17% in Q4 2025.
Hyperfine (HYPR) Return on Capital Employed (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Return on Capital Employed data on file, last reported at 72.91% in Q1 2026.
- Quarterly Return on Capital Employed rose 1736.0% year-over-year to 72.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 72.91% (up 1736.0% YoY) and the FY2025 annual result came in at 81.78%, down 1804.0% from the prior year.
- Return on Capital Employed grew to 72.91% in Q1 2026, from 101.17% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 45.1% in Q1 2022 to a low of 121.01% in Q3 2025.
- A 5-year average of 69.13% and a median of 60.56% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed slumped 5108 bps — and 2026, when it soared 1736 bps.
- Tracing HYPR's Return on Capital Employed over 5 years: stood at 55.8% in 2022, then grew by 4 bps to 53.54% in 2023, then tumbled by 46 bps to 78.0% in 2024, then dropped by 30 bps to 101.17% in 2025, then gained by 28 bps to 72.91% in 2026.
- The last three Return on Capital Employed figures came in at 72.91% (Q1 2026), 101.17% (Q4 2025), and 121.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Hyperfine | 90.12 Mn | 45.35 Mn | 1.98 Mn | -64.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -64.59% |
| Mar 31, 2026 | -72.91% |
| Dec 31, 2025 | -101.17% |
| Sep 30, 2025 | -121.01% |
| Jun 30, 2025 | -102.20% |
| Mar 31, 2025 | -90.27% |
| Dec 31, 2024 | -78.00% |
| Sep 30, 2024 | -69.94% |
| Jun 30, 2024 | -62.13% |
| Mar 31, 2024 | -56.42% |
| Dec 31, 2023 | -53.54% |
| Sep 30, 2023 | -50.30% |
| Jun 30, 2023 | -47.24% |
| Mar 31, 2023 | -52.58% |
| Dec 31, 2022 | -55.80% |
| Sep 30, 2022 | -60.56% |
| Jun 30, 2022 | -55.97% |
| Mar 31, 2022 | -45.10% |
| Dec 31, 2021 | -34.24% |